| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 15.714 | 104.090 | 150.895 |
| Total Income - EUR | - | - | - | - | - | - | - | 18.592 | 109.680 | 163.954 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 64.172 | 194.520 | 181.266 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | -45.580 | -84.839 | -17.312 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | -45.737 | -85.883 | -17.312 |
| Employees | - | - | - | - | - | - | - | 1 | 2 | 2 |
Check the financial reports for the company - Abro Medical International S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 114.606 | 103.717 | 81.985 |
| Current Assets | - | - | - | - | - | - | - | 48.031 | 73.772 | 62.116 |
| Inventories | - | - | - | - | - | - | - | 9.489 | 21.488 | 24.664 |
| Receivables | - | - | - | - | - | - | - | 31.339 | 45.202 | 24.553 |
| Cash | - | - | - | - | - | - | - | 7.203 | 7.082 | 12.899 |
| Shareholders Funds | - | - | - | - | - | - | - | -45.636 | -131.380 | -147.958 |
| Social Capital | - | - | - | - | - | - | - | 101 | 101 | 101 |
| Debts | - | - | - | - | - | - | - | 208.462 | 309.852 | 292.119 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3250 - 3250" | |||||||||
| CAEN Financial Year |
3250
|
|||||||||
Comments - Abro Medical International S.r.l.